EUVIMEDEUVIMED entdecken
Kommentar

Do They, or Don't They? Integrase Strand Transfer Inhibitors, Tenofovir Alafenamide, and Excessive Weight Gain in People With HIV

David Alain Wohl iD

The Journal of Infectious Diseases · 15.10.2026 · 234 (4) · 497-499

DOI: 10.1093/infdis/jiag365 ↗

Kurz gefasst

Kommentar in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 16.07.2026. Verfasst von David Alain Wohl. Beteiligte Einrichtung: The Institute of Global Health and Infectious Diseases, The University of North Carolina at Chapel Hill. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

HIVantiretroviral adverse effectsweight gain

Autor:innen und Institutionen

  • The Institute of Global Health and Infectious Diseases, The University of North Carolina at Chapel Hill.

ORCID-Profile: David Alain Wohl

Zitieren

APA

Wohl, D. A. (2026). Do They, or Don't They? Integrase Strand Transfer Inhibitors, Tenofovir Alafenamide, and Excessive Weight Gain in People With HIV. The Journal of Infectious Diseases, 234(4), 497-499. https://doi.org/10.1093/infdis/jiag365

Vancouver

Wohl DA. Do They, or Don't They? Integrase Strand Transfer Inhibitors, Tenofovir Alafenamide, and Excessive Weight Gain in People With HIV. The Journal of Infectious Diseases. 2026;234(4):497-499. doi:10.1093/infdis/jiag365

BibTeX
@article{Wohl2026,
  author = {Wohl, David Alain},
  title = {Do They, or Don't They? Integrase Strand Transfer Inhibitors, Tenofovir Alafenamide, and Excessive Weight Gain in People With HIV},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  volume = {234},
  number = {4},
  pages = {497--499},
  doi = {10.1093/infdis/jiag365}
}
Kostenlos starten →